1. Fred Hassan - Schering-Plough - $49.65M
2. Bill Weldon - Johnson & Johnson - $30M
3. Miles White - Abbott Laboratories - $26.2M
4. John Lechleiter - Eli Lilly - $20.9M
5. Daniel Vasella - Novartis - $20.24M
6. Jim Cornelius - Bristol-Myers Squibb - $18.2M
7. Richard Clark - Merck - $16.8M
8. Robert Coury - Mylan - $16M
9. Jeffrey Kindler - Pfizer - $14.8M
10. Frank Baldino - Cephalon - $11.1M
via fiercepharma.com
Aucun commentaire:
Enregistrer un commentaire